GE HealthCare receives FDA approval for Flyrcado PET radiotracer, set to transform coronary artery disease diagnosis

Pallavi Madhiraju- September 29, 2024 0

GE HealthCare has received the US Food and Drug Administration (FDA) approval for Flyrcado (flurpiridaz F-18), a breakthrough PET radiotracer poised to transform the diagnosis ... Read More

TUXEDO-2 trial wraps up enrolment: Could Sahajanand Medical Technologies’ stent revolutionise diabetes care?

Pallavi Madhiraju- August 18, 2024 0

In a landmark achievement for cardiovascular medicine, Sahajanand Medical Technologies has announced the successful completion of patient enrolment for the TUXEDO-2 clinical trial in India. ... Read More

HeartFlow unveils HeartFlow Plaque Analysis platform for CAD risk assessment

Pallavi Madhiraju- July 21, 2024 0

HeartFlow, Inc., a leading innovator in non-invasive artificial intelligence (AI) solutions for heart care, has launched its next-generation HeartFlow Plaque Analysis platform. This advanced tool, ... Read More

Concept Medical gets FDA IDE approval for MagicTouch PTA for Superficial Femoral Arteries

Pallavi Madhiraju- May 30, 2023 0

Concept Medical has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) for its Sirolimus Coated Balloon (SCB) MagicTouch PTA ... Read More

AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn

Raghuram Kadari- January 10, 2023 0

AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More

Bracco Diagnostics gets FDA nod for CardioGen-82 infusion system

pharmanewsdaily- October 18, 2020 0

Bracco Diagnostics, the US subsidiary of Italian diagnostic imaging company Bracco Imaging, has secured approval from the US Food and Drug Administration (FDA) for its ... Read More